Riskpilot← Back to searchSign inGet full accessBoule Diagnostics AB
ABActiveOrg 5565350252Domnarvsgatan 4Research and experimental development on natural sciences and engineering · NACE 7210Est. 199610-19 employees
Revenue 2024
SEK 28,9M
0% vs 2023
EBITDA margin
-19.9%
-489% vs 2023
Equity ratio
83.3%
Financial strength
Net profit 2024
SEK 74,3M
+257% vs 2023
| Revenue | SEK 28,9M | +0% |
| EBITDA | SEK -5,7M | -489% |
| Net profit | SEK 74,3M | +257% |
| Total assets | SEK 462,5M | +36% |
| Equity | SEK 385,5M | +24% |
| Employees | — | — |
Legal name
Boule Diagnostics AB
Org number
5565350252
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 oktober 1996
Share capital
SEK 9 708 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna Nielsen, Torben i förening med externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, själv eller via dotterbolag, bedriva rörelse inom verksamheter med medicinsk- och bioteknisk inriktning, äga och förvalta lös och fast egendom samt annan därmed förenlig verksamhet.
Address
Domnarvsgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 17 742 | — | 24 127 | 26 006 | 27 943 | 28 789 | 28 858 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −1 888 | −7 689 | −11 844 | −10 707 | 0 | −475 | 2 | 253 | 1 476 | −5 735 |
| Depreciation & amort. | — | — | — | −0 | — | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 888 | −7 689 | −11 844 | −10 707 | 0 | −475 | 2 | 253 | 1 476 | −5 735 |
| Net financials | −60 | −51 | −3 | −10 | — | −33 437 | 14 998 | 49 | 17 645 | 78 922 |
| Profit before tax | −126 | 17 235 | 17 560 | −2 505 | 0 | −33 912 | 15 000 | 302 | 19 121 | 73 187 |
| Tax | −0 | 4 735 | −4 735 | −0 | — | 66 | −123 | 72 | 1 695 | 1 117 |
| Net profit | −126 | 21 970 | 12 825 | −2 505 | — | −33 846 | 14 877 | 374 | 20 816 | 74 304 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 189 907 | 216 379 | 228 536 | 243 700 | — | 184 929 | 179 742 | 305 671 | 340 456 | 462 478 |
| Equity | 177 430 | 196 721 | 213 762 | 201 550 | — | 157 784 | 161 965 | 290 890 | 311 147 | 385 451 |
| Long-term debt | 1 250 | 0 | 0 | 0 | — | 3 288 | 3 899 | 3 133 | 3 442 | 3 364 |
| Short-term debt | 11 227 | 19 658 | 14 774 | 39 450 | — | 23 857 | 13 877 | 11 647 | 25 867 | 73 663 |
| Total debt | 12 477 | 19 658 | 14 774 | 39 450 | — | 27 145 | 17 776 | 14 780 | 29 309 | 77 027 |
EBITDA margin
-19.9%
This company
15.8%
Market median
-226% vs market
20152024
Equity ratio
83.3%
This company
38.2%
Market median
+118% vs market
20152024
Return on equity
19.3%
This company
18.4%
Market median
+5% vs market
20152024
Net profit margin
257.5%
This company
8.1%
Market median
+3079% vs market
20152024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20152024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AC Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
MC External Signatory | External Signatory | 2026 | — | — |
HL External Signatory | External Signatory | 2024 | — | — |
JF Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
LG Chief Auditor | Chief Auditor | 2022 | — | — |
TN Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
KL Chief Auditor | Chief Auditor | 2021 | — | — |
AI External Signatory | External Signatory | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Boule Diagnostics AB (this company)
Llc Boule ProductionBOULE MEDICAL S.A DE C.VLLC BOULE PRODUCTIONLlc Boule MedicalLLC BOULE MEDICALBoule Medical S.A De C.vCLINICAL DIAGNOSTIC SOLUTIONS INCClinical Diagnostic Solutions IncBoard members of Boule Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Christina Rubenhag | Chief Executive Officer | 0 companies |
| Michael Carl Ewert af Winklerfelt | External Signatory | 0 companies |
| Holger Lembrér | External Signatory | 0 companies |
| Jesper Filip Gustaf B Söderqvist | Chief Executive Officer | 0 companies |
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Torben Nielsen | Chief Executive Officer | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Annette Ingegerd Marie Colin | External Signatory | 0 companies |
| Yvonne Christine Mårtensson | Board of Directors | 0 companies |
| Rikke Rytter Hansen | Board of Directors | 0 companies |
| Torben Jörgensen | Chairman | 0 companies |
| Emil Lars Robert Hjalmarsson | Board of Directors | 0 companies |
| Gustaf Peter Reinhold von Ehrenheim | Chairman | 0 companies |
| Anna Charlotta Falvin | Board of Directors | 0 companies |
| Thomas Lennart Eklund | Board of Directors | 0 companies |
| Jon Anders Risfelt | Board of Directors | 0 companies |
| Torben Vedel Stahl Jørgensen | Chairman | 0 companies |
| Karin Cecilia Dahllöf | Board of Directors | 0 companies |